Zucara Therapeutics, Inc.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.zucara.ca
Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Phase 2
Recruiting
- Conditions
- Type 1 Diabetes Mellitus with Hypoglycemia
- Interventions
- Drug: PlaceboDrug: ZT-01, 7 mgDrug: ZT-01, 22 mgDrug: ZT-01, 15 mg
- First Posted Date
- 2023-03-09
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Zucara Therapeutics Inc.
- Target Recruit Count
- 186
- Registration Number
- NCT05762107
- Locations
- 🇺🇸
Headlands Research, Escondido, California, United States
🇺🇸USC Keck Medicine Eastside Center for Diabetes, Los Angeles, California, United States
🇺🇸LCGK Research, San Carlos, California, United States
Effect of ZT-01 on Glucagon During Hypoglycemia in Type 1 Diabetes Mellitus
Phase 1
Terminated
- Conditions
- HypoglycemiaType 1 Diabetes
- Interventions
- Drug: ZT-01 low doseDrug: ZT-01 high doseDrug: Placebo
- First Posted Date
- 2021-08-17
- Last Posted Date
- 2023-07-12
- Lead Sponsor
- Zucara Therapeutics Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT05007977
- Locations
- 🇨🇦
LMC Manna Research, Toronto, Ontario, Canada
News
No news found